Anna Wilhelmson

Anna Wilhelmson is a Senior Researcher at the Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen, working within the Porse Group. Her research focuses on the intersection of hematology, immunology, and cancer biology with particular emphasis on molecular mechanisms underlying blood disorders.

Her primary research interests include:

• Molecular mechanisms of acute myeloid leukemia
• Role of sex hormones in cardiovascular disease and immune function
• B cell development and function
• Hematopoietic stem cell biology
• Transcriptional regulation in blood cell development
• Genetic mutations in cancer progression

Dr. Wilhelmson's publication record demonstrates a strong trajectory of research focused on understanding genetic and hormonal influences on blood cell development and disease. Her work spans from fundamental stem cell biology to clinical implications of molecular findings in leukemia and cardiovascular disease. She has published in high-impact journals including Nature Communications, Haematologica, and Cell Reports, with her 2025 paper on testosterone's role in myocardial infarction representing her most recent contribution.

Her research has gained significant attention in the scientific community, with multiple publications covered by news outlets and widely shared across social media platforms. Several of her papers have been highlighted by major news organizations and academic sharing networks.

As a member of the Porse Group, Dr. Wilhelmson collaborates extensively with researchers across Denmark and internationally, contributing to the group's reputation in hematopoietic stem cell research and leukemia biology. Her work frequently bridges basic science with potential clinical applications, particularly in understanding how genetic mutations cooperate to drive disease progression.